Antihistamines News and Research

RSS
Anti-itching drug clemizole shows promise against hepatitis C

Anti-itching drug clemizole shows promise against hepatitis C

Gleevec receives FDA priority review for gastrointestinal stromal tumors after surgery

Gleevec receives FDA priority review for gastrointestinal stromal tumors after surgery

Drugs and fruit juices - a combination to avoid

Drugs and fruit juices - a combination to avoid

New reasons to avoid grapefruit juice when taking certain drugs

New reasons to avoid grapefruit juice when taking certain drugs

Despite warnings one in ten children still use cough and cold medications

Despite warnings one in ten children still use cough and cold medications

Overuse of cough and cold medications among young children in U.S.

Overuse of cough and cold medications among young children in U.S.

Dimebon, old hay fever drug shows promise in treating Alzheimer's

Dimebon, old hay fever drug shows promise in treating Alzheimer's

New hay fever jab promises year long relief for sufferers

New hay fever jab promises year long relief for sufferers

Allergy expert says expect cure for peanut allergy in five years

Allergy expert says expect cure for peanut allergy in five years

Beta arrestins found to generate new proteins

Beta arrestins found to generate new proteins

Doctors should consider alternatives to antibiotics for sinusitis

Doctors should consider alternatives to antibiotics for sinusitis

Taro Pharmaceutical receives final FDA approval for Cetirizine Hydrochloride oral solution

Taro Pharmaceutical receives final FDA approval for Cetirizine Hydrochloride oral solution

Over-the-counter sale of child cough medicine for young children to be banned

Over-the-counter sale of child cough medicine for young children to be banned

Naglazyme approved in Japan

Naglazyme approved in Japan

FDA gives new safety information on proper use of Tussionex as a cough suppressant

FDA gives new safety information on proper use of Tussionex as a cough suppressant

FDA approves XYZAL (levocetirizine dihydrochloride) for allergies and chronic idiopathic urticaria

FDA approves XYZAL (levocetirizine dihydrochloride) for allergies and chronic idiopathic urticaria

Discovery of 'overdrive' protein could broaden drug design options

Discovery of 'overdrive' protein could broaden drug design options

Baxter's multiple-dose vial Heparin linked to severe allergic reactions

Baxter's multiple-dose vial Heparin linked to severe allergic reactions

Allergic-like reactions occur in premedicated patients

Allergic-like reactions occur in premedicated patients

OTC cough medicine: Not worthwhile for children or adults?

OTC cough medicine: Not worthwhile for children or adults?